CNO Financial Group (CNO) Q4 2025 earnings review
Record Sales Momentum Masks GAAP Noise
CNO Financial closed 2025 with strong operational execution, marking its 14th consecutive quarter of sales growth and record full-year premiums (+15%). However, the headline GAAP numbers are messy: Net Income fell nearly 50% YoY ($93M vs $183M) due to non-economic investment volatility and impairments. Looking past the noise, Net Operating Income (NOI) accelerated 12% to $1.47/share. The strategic exit from the Worksite fee business is dragging top-line fee revenue but is accretive to margins. The company enters 2026 with 8.9% ROE and a clear, albeit capital-intensive, path to its 2027 targets.
🐂 Bull Case
Total New Annualized Premiums (NAP) grew 15% in 2025, setting a new record. The Consumer division continues to dominate the middle-market niche with 14 consecutive quarters of growth, proving the distribution model is resilient regardless of macro headwinds.
Operating ROE (ex-significant items) held strong at 11.4%. With the drag of the unprofitable Worksite fee business removed and yield on the investment portfolio expanding (New Money Rates >6%), structural profitability is improving.
🐻 Bear Case
Fee income fell 7% YoY in Q4 and 49% for the full year. While deliberate due to the Worksite exit, this removes a diversification lever and places more pressure on underwriting margins and investment income to carry growth.
GAAP Net Income was crushed by $25.2M in net realized investment losses and negative market value changes. While 'non-operating,' these persistent hits to book value complicate the capital return narrative.
⚖️ Verdict: 🟢
Bullish. Ignore the GAAP volatility. The core insurance engine is accelerating (NOI +12%), sales are at record highs, and management is successfully pruning dead weight (Worksite fee business) to boost ROE.
Key Themes
TechMod Expense Drag
The company incurred $9.9M in expenses related to 'TechMod' (technology modernization) in Q4 alone. While necessary for long-term efficiency, this line item is becoming a notable drag on non-operating results and free cash flow that investors must model for the next 2-3 years.
Health Segment Profitability
The Health segment remains the crown jewel, generating $139.4M in margin in Q4, up from $130.1M a year ago. Despite noise about Medicare Supplement utilization rates in previous quarters, the segment delivered solid margin expansion sequentially from Q1/Q2 levels.
Fee Income Collapse
Fee income has effectively halved year-over-year ($15.2M FY25 vs $30.0M FY24), primarily due to the exit from the Worksite fee services business. While this improves the margin profile by removing a loss-making entity, it reduces revenue diversity. The Q4 fee income of $19.1M suggests some stabilization, but the growth engine here is broken.
Investment Income Tailwinds
Net Investment Income (allocated to products) grew 7% YoY in 2025 ($1,067M vs $1,040M margin impact). With new money rates consistently above 6% for 11+ quarters, the portfolio yield is actively repricing higher, providing a predictable tailwind for spread-based products like annuities.
Capital Return Volatility
Share buybacks slowed significantly in Q4 ($60M) compared to Q2 ($100M) and Q1 ($100M). While the company maintained dividends, the reduced buyback pace suggests capital is being preserved for the Bermuda reinsurance capital strain or the TechMod cash outlay.
Worksite Division Restructuring
The company recorded a $17.3M net loss related to the divested Worksite business in Q4. This 'rip the band-aid off' approach is painful in GAAP terms ($101.9M impairment in Q3), but cleans the deck for 2026. The remaining Worksite *insurance* business continues to grow (NAP +20% in Q3), validating the decision to cut the services arm.
Other KPIs
Stable. Up 4% year-over-year from $37.35. This steady accretion validates the underlying earnings power despite the noisy GAAP net income results.
Stable. Flat vs 2024 (11.4%). Management's target is to expand this spread, and the exit of loss-making fee businesses is the primary lever to push this toward the 12%+ range in 2026/2027.
Strong. Down from $372.5M a year ago but remains robust. This liquidity buffer supports the dividend and provides optionality for opportunistic buybacks if the stock price dislocates.
Guidance
Management reiterated they are on a 'path to achieving our 2027 ROE target.' Previous disclosures sized this as a 200bps improvement over the 2024 baseline (~10%), implying a target of ~12% by 2027.
Management stated they 'achieved, and in most cases exceeded, all 2025 guidance metrics.' This retrospective confirmation signals credibility in their forecasting ability.
Key Questions
TechMod Cash Burn
With $9.9M expensed in Q4, what is the projected cadence of TechMod expenses for FY26, and will these costs accelerate before they decline?
Buyback Deceleration
Share repurchases slowed to $60M in Q4 from a $100M run-rate in H1. Is this the new normal to preserve capital for the Bermuda reinsurance strategy, or a temporary pause?
Fee Income Floor
After the divestiture of the Worksite fee business, does the $19M in Q4 fee income represent a stable baseline, or is there further erosion expected as the exit finalizes in 1H 2026?